Regeneron: Q1 Earnings Snapshot

By The Associated Press
April 29, 2026 | 6:44 AM

TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Wednesday reported first-quarter earnings of $727.2 million.

The Tarrytown, New York-based company said it had profit of $6.75 per share. Earnings, adjusted for stock option expense and non-recurring costs, came to $9.47 per share.

The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $8.52 per share.

The biopharmaceutical company posted revenue of $3.61 billion in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $3.44 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGN

Ben Simmons agrees to a 1-year contract with the Sacramento Kings, AP source says

By The Associated Press
September 4, 2026 | 12:37 PM

Ben Simmons is making a comeback to the NBA after sitting out last season with injuries, agreeing to a one-year contract with the Sacramento Kings. A person familiar with the deal confirmed to The Associated Press that he will sign with Sacramento. The person spoke to the AP on condition of anonymity because the deal hadn't been announced. ESPN first reported the move and said Simmons would be paid $3.5 million. The 30-year-old from Australia is a former No. 1 draft pick, three-time All-Star and Rookie of the Year, but he has struggled to perform and stay healthy in recent years. He sat out last season while dealing with back and leg injuries after ending the 2024-25 season in a reserve role for the Los Angeles Clippers.

Related Stories